Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.

Abstract

Patients with schizophrenia treated with atypical antipsychotics had a moderately increased risk of DM relative to those treated with conventional antipsychotics, as measured by Cox proportional hazards models; such risk was not significantly different among patients treated with individual atypical medications.